Arterial distensibility in subjects with white-coat hypertension with and without diabetes or dyslipidaemia: Comparison with normotensives and sustained hypertensives

Blood Pressure Monitoring

Volumn 5, Issue 1, 2000, Pages 11-17

  Ribeiro, Laura ^a   Gama, Guilherme ^a   Santos, Alejandro ^a   Asmar, Roland ^b   Martins, Luis ^a   Polónia, Jorge ^a,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b Inst Rech Form Cardiovasculaire   (France)

^c HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

Ambulatory blood pressure; Cardiovascular risk factors; Essential hypertension; Pulse wave velocity; White coat hypertension

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

ADULT; AORTA WALL; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PULSE WAVE; SMOKING; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION;

EID: 0034085108     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126097-200002000-00003     Document Type: Article

References (38)

1. 1 Devereux RB, de Simone G, Ganau A, Koren MJ, Roman MJ. Left ventricular hypertrophy associated with hypertension and its relevance as a risk factor for complications. J Cardiovasc Pharmacol 1993; 21 (suppl 2):S38-S44.
2. 2 Ferrara LA, Mancini M, Celentano A, Galderisi M, Iannuzzi R, Marotta T, et al. Early changes of the arterial carotid wall in uncomplicated primary hypertensive patients. Study by ultrasound high-resolution B-mode imaging. Arterioscler Thromb 1994; 14:1290-1296.
3. 3 Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976; 38:46-51.
4. 4 Goode GK, Miller JP, Heagerty AM. Hyperlipidaemia, hypertension, and coronary heart disease. Lancet 1995; 345:362-364.
5. 5 Sowers JR, Khoury S. Diabetes and hypertension [review]. Primary Care 1991; 18:509-524.
6. 6 Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989; 149:1514-1520.
7. 7 Selby JV, Fitz Simmons SC, Newman JM, Katz PP, Sepe S, Shwostack J. The natural history and epidemiology of diabetic nephropathy: implications for prevention and control. JAMA 1990; 263:1954-1960.
8. 8 Wilson PW, Hoeg JM, D'Agostino RB, Silbershatz H, Belanger AM, Poehlmann H, et al. Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. N Engl J Med 1997; 337:516-522.
9. 9 The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-2446.
10. 10 Mancia G, Parati G. Clinical significance of 'white coat' hypertension. Hypertension 1990; 16:624-626.
11. 11 Pickering TG. White-coat hypertension in a changing era of medical care. Blood Press Monit 1996; 1 (suppl 2):S27-S32.
12. 12 White WB, Schulman P, McCabe EJ, Dey HM. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 1989; 261:873-877.
13. 13 Pierdomenico SD, Lapenna D, Guglielmi MD, Antidormi T, Schiavone C, Cuccurullo F, et al. Target organ status and serum lipids in patients with white coat hypertension. Hypertension 1995; 26:801-807.
14. 14 Cavallini MC, Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy? Hypertension 1995; 26:413-419.
15. 15 Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24:793-801.
16. 16 Cardillo C, De Felice F, Campia U, Folli G. Psychophysiological reactivity and cardiac end-organ changes in white coat hypertension. Hypertension 1993; 6:836-844.
17. 17 Kuwajima I, Suzuki Y, Fujisawa A, Kuramoto K. Is white coat hypertension innocent? Structure and function of the heart in the elderly. Hypertension 1993; 22:826-831.
18. 18 Ferrara LA, Guida L, Pasanisi F, Celentano A, Palmieri V, Iannuzzi R, et al. Isolated office hypertension and end-organ damage. J Hypertens 1997; 15:979-985.
19. 19 Bidlingmeyer I, Burnier M, Bidlingmeyer M, Waeber B, Brunner HR. Isolated office hypertension: a prehypertensive state? J Hypertens 1996; 14:327-332.
20. 20 Polonia J, Santos A, Gama G, Basto F, Bettencour P, Martins L. Clinic and 24-h ambulatory blood pressure values in normotensives and in untreated white-coat hypertensive patients evaluated before and after 3.5 years. Blood Press Monit 1997; 2:289-295.
21. 21 Arnet DK, Evans GW, Riley WA. Arterial stiffness: a new cardiovascular risk factor. Am J Epidemiol 1994; 140:669-682.
22. 22 Avolio AP, Pulse wave velocity and hypertension. In: Safar M (editor): Arterial and venous systems in essential hypertension. Boston, MA: Martinus-Nijhoff; 1991. pp. 133-152.
23. 23 Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurements. Validation and clinical application studies. Hypertension 1995; 26:485-490.
24. 24 National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28:1039-1057.
25. 25 Sahn DJ, De Maria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
26. 26 Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55:613-618.
27. 27 Borges N, Polonia J. Use of spreadsheet for statistical and graphical processing of records from the ambulatory blood pressure monitor Spacelabs 90207. Rev Port Cardiol 1993; 12:313-319.
28. 28 Wilkinson IB, Cockcroft JR, Webb DJ. Pulse wave analysis and arterial stiffness. J Cardiovasc Pharmacol 1998; 32:S33-S37.
29. 29 McVeigh GE, Brennan G, Cohn JN, Finkelstein S, Hayes R, Johnston D. Reduced vascular compliance as a marker of essential hypertension. Am J Hypertens 1991; 4:245-251.
30. 30 McVeigh GE, Brennan G, Cohn JN, Finkelstein S, Hayes R, Johnston D. Vascular abnormalities in non-insulin dependent diabetes mellitus identified by arterial waveform analysis. Am J Med 1993; 95:424-430.
31. 31 Dart AM, Lacombe F, Yeoh JK, Cameron JD, Jennings GL, Laufer E, et al. Aortic distensibility in patients with isolated hypercholesterolaemia, coronary artery disease or cardiac transplantation. Lancet 1991; 338:270-273.
32. 32 Cockcroft JR, Wilkinson IB, Webb DJ. Age, arterial stiffness and the endothelium. Age Ageing 1997; 26 (suppl 4):53-60.
33. 33 Asmar R, Benetos A, London G, Hugue CH, Weiss Y, Topouchian J, et al. Aortic distensibility in normotensive, untreated and treated hypertensive patients. Blood Press 1995; 4:48-54.
34. 34 Woolan GL, Schnur PI, Valibona C, Hoff HE. Pulse wave velocity and 'aortic ejection time' in healthy men and in men with coronary artery disease. Circulation 1960; 22:126-129.
35. 35 McDonald DA. Regional pulse-wave velocity in the arterial tree. J Appl Physiol 1967; 24:73-78.
36. 36 Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible? Am J Coll Cardiol 1997; 30:325-333.
37. 37 1999 World Health Organization - International Society of Hypertension for the management of Hypertension. J Hypertens 1999; 17:151-183.
38. 38 Fagard R, Bielen E, Staessen J, Thijs L, Amery A. Response of ambulatory blood pressure to antihypertensive therapy guided by clinic pressure. Am J Hypertens 1993; 6:648-653.